Sary This study aimed to determine the expession of Nm23-H1 in colorectal cancer and lver metastases and to correlate N1m23-HI expression with dinicopathological variabe Simens from 59 primary colorctal camns and five liver metastases were studied usin Northern blot hybriTisauion. The mean ± sc. of tumour/normal (I/N) ratio of Nm23-H1 RNA expreson was 4.3 ± 0.4 (P<0.001) and 5.1 ± 0.90 (P<0.01) for co_oectal cancer and iver tsases rI ty. No significant relationship was observed b n the klv of Nm23-Hl RNA and the patent's age, scx, tumour location, differntiation, prmnce of lymph node involvement or distant metatases Nm23-H1 RNA kvel was 2.6 ± 0.5 for tumour size less than 3.0 an and 4.6 ± 0.5 for those > 3.0 an (P = 0.05). Ther a ed to be a trend between ireasg lative Nm23-Hl RNA and bowel wal invasi, ispec of metastatic status (Ti = 1.9 ± 0.3, T2 = 4.1 0.6, T3 = 4.1 ± 0.5 and T4 = 6.4 ± 1.6). Tumour specimens were obtained from the tumour edge, thus avoiding a necrotic centre. Gross normal
RNA and bowel wal invasi, ispec of metastatic status (Ti = 1.9 ± 0.3, T2 = 4.1 0.6, T3 = 4.1 ± 0.5 and T4 = 6.4 ± 1.6). Ths (Steeg et al., 1988a) . A tumour metastases-suppressor function was implicated by the reduced expression of Nm23 in highly metastatic sublines compared with non-metastatic sublines derived from the same K-1735 clone (Steeg et al., 1988a,b; Rosengard et al., 1989 , Leone et al., 1991 . Furthermore, transfection of Nm23-HI cDNA into highly metastatic K-1735 melanoma cell lines reduced their metastatic potential, independent of growth rate (Leone et al., 1991) . Thus far, a murine pNM23-Hl (Steeg et al., 1988a) and human pNM23-HI (Rosengard et al., 1989) Nm23 cDNA clones have been characterised. Both encode for a Mr 17,000 nuclear and cytoplasmic protein containing 152 amino acids (Leone et al., 1991) . The gene is located on chromosome 17q22 (Varesco et al., 1992) . A second human gene, Nm23-H2, was identified and shown to encode a protein with 88% identity to the product of Nm23-H1 (Stahl et al., 1991) , and to be located in the same chromosomal region as Nm23-H1 (Backer et al., 1993) . These genes share a high degree of homology with the awd developmental gene in Drosophila (Rosengard et al., 1989) and the nudeoside diphosphate (NDP) kinase gene in Dictyosteliun (Wallet et al., 1990) . The Nm23-HI and Nm23-H2 genes have been shown to be identical to the human NDP kinase A and B chains respectively (Gilles et al., 1991) . Several studies (Belivacqua et al., 1989; Barnes et al., 1991; Hennessey et al., 1991; Hirayama et al., 1991; Royds et al., 1993) (Florenes et al., 1992) and the presence of hepatoceliular carcinoma metastases (Nakayama et al., 1992) , incresed Nm23 expression has been associated with a decrease in squamous cell lung cancer (Engel et al., 1993) and neuroblastoma (Hailat et al., 1991; Leone et al., 1993) disease-free survival as well as with advanced (anaplastic) thyroid cancer stages (Zou et al., 1993) . However, other studies have shown that increased Nm23 expression in lung (Higashiyama et al., 1992) in the non-metastatic lesions (Wang et al., 1993) . Furthermore, a somatic allelic loss of Nm23 in one cancer patient and a homozygous deletion in a lymph node metastases in another patient (Leone et al., 1991) indicate a possible Metastases-suppressor role for Nm23 in colorectal cancer. However, increased Nm23-Hl and Nm23-H2 RNA in colorectal cancer relative to adjaent normal colonic mucosa has been noted in both early and advanced stages, with no relationship to metastatic activity (Haut et al., 1991; Myeroff & Markowitz 1993) .
The aim of this study was to determine, in a large series of human primary colorectal cancer and liver metastases, the mucosa specimens were obtained from the surgical resection margin by sharply dissecting the mucosa off the muscularis propria. Surgical specimens consisted of 59 primary colorectal cancer and paired adjacent mucosa and five liver metastases from colorectal cancer and paired normal liver including two cases with synchronous liver metastases. None of the patients had received previous radiation or chemotherapy.
Of the 59 primary colorectal cancer patients, 34 patients (57.6%) were men and 25 (42.4%) were women. Their age was 66.7 ± 10.8 (mean ± s.e.) with a range from 41 to 87 years. The tumours were located in the caecum (n = 5), ascending colon (n = 14), transverse colon (3), descending colon (n = 8), sigmoid colon (n = l1) and rectum (n = 18). According to the International TNM staging system (Hermanek & Sobin 1987) , four (6.8%) of the lesions were TI, 11 (18.6%) were T2, 36 (61.0%) were T3 and eight (13.6%) were T4. Histologically, there were four (7.2%) welldifferentiated, 43 Northern blot analyses Frozen tissue specimens were homogenised in 4 M guanidinium thiocyanate followed by ultracentrifugation through a caesuim chloride cushion, as previously described (Guillem et al., 1990 Blots were washed to a final stringency of 65"C in 0.1 x SSC and 0.1% SDS. Autoradiography was performed at -80'C with an intensifying screen. For rehybridisation, the bolts were stripped by incubation in 0.1 x SSPE-0.5% SSC, 100lC for 5 min. Blots were autoradiographed overnight to ensure that all of the probe was removed before rehybridising with a 2-microglobulin probe.
Probes
The Nm23H-I probe is a 900 bp BamHI restriction endonuclease DNA fragment of human Nm23-HI gene obtained from the plasmid PNM23-HI. DNA fragments were purified and recovered by low melting agarose gel electrophoresis using GeneClean (BIO 101, La Jolla, Ca. USA). A human 2-microglobulin (P2-M) cDNA clone (Suggs et al., 1981) and centrifuged at 5,000 g for 20 min. The supernatant was stored at -80°C.
Tumour and normal mucosa extracts (50 gig) were electrophoresed on a 15% SDS-PAGE gel using a Minigel apparatus (Bio-Rad, Richmond, CA, USA). Separated proteins were transferred to nitrocellulose membranes (Amersham, Bucks, UK) in Tris/glycine buffer (2.5 mM Tris, 192 mM glycine and 20% methanol) at 4°C and 100 V using a Mini system. Non-specific binding sites were blocked for I h at room temperature in 10 mM Tris buffer containing 150 mM sodium chloride and 0.5% Tween 20 (TBS-T) with 4% bovine serum albumin. The blots were incubated overnight at 4°C in a 1:500 dilution of a polyclonal antibody specific for Nm23-Hl and then washed several times with TBS-T, followed by an incubation step with horseradish peroxidaselabelled anti-rabbit antibody (1 :5,000 in TBS-T for 30 min at room temperature). Then, after washing with TBS-T, an enhanced chemiluminescence detection system (ECL, Amersham) was used. For molecular weight determination, ECL protein molecular weight marker and rainbow-coloured protein molecular weight marker (Amersham) were used.
Densitometric quantitation
Nm23-H I RNA and protein levels were quantitated by measuring the intensities of the appropriate 'bands' in autographs using LKB XL laser densitometry (Pharmacia LKB Biotechnology, Uppsala, Sweden).
The RNA results were expressed as the fold increase of a 0.8 kb Nm23 transcript in tumours compared with that in the paired normal tissues, $3-M mRNA transcnrpts were used as internal controls: 
Reskts
Nm23-HJ RNA expression in prinary colorectal cancer Total cellular RNA from 59 matched pairs of human colorectal cancer and adjacent normal mucosa were examined for expression of Nm23-HI RNA by Northern blot hybridisation. Figure 1 shows the expression of a 0.8 kb Nm23-Hl transcript in total cellular RNA from tumour and matched normal tissue. It suggests that Nm23-Hl mRNA levels were elevated in colorectal cancer compared with those in normal colon tissues. Densitometric analyses of the Northern blots by comparison with normal mucosa indicated that Nm23-Hl Table I . No significant relationship was observed between the T/N fold increase in Nm23-HI RNA and the patient's sex (P = 0.67), age (P = 0.53), tumour location (P = 0.99) or tumour differentiation (P = 0.99). Lower levels of Nm23-HI RNA expression were found in small tumours. The mean Nm23 RNA level was 2.6 ± 0.5 for tumours less than 3.0 cm and 4.6 ± 0.5 for those equal to or greater than 3.0 cm. This difference was statistically significant (P = 0.05).
Relationship bet%,een Nm23-HJ expression and local tumour invasion The T/N fold increase in Nm23-Hl RNA for TI, T2, T3 and T4 lesions was 1.9 ± 0.3; 4.1 ± 0.6; 4.1 ± 0.5 and 6.4 ± 1.6 respectively. Although there appeared to be a trend between increasing relative Nm23-Hl RNA overexpression and degree of bowel wall penetration, irrespective of lymph node and distant metastases status, statistical significance (P<0.01) was achieved only when superficial lesions (TI) were compared with advanced ones (T2, T3 and T4).
Relationship between Nm23-HJ RNA level and colorectal cancer metastases Figure 2 displays (Steeg et al., 1988a) , human breast cancer (Bevilacqua et al., 1989; Barnes et al., 1991; Hennessey et al., 1991; Tokunaga et al., 1993) hepatocellular carcinoma (Nakayama et al., 1992) and melanoma (Florenes et al., 1992) (Haut et al., 1991; Myeroff & Markowitz, 1993) . Furthermore, in small series of patients, the extent of Nm23 expression was found to be similar between metastatic and non-metastatic lesions (Haut et al.. 1991 (Florenes et al., 1992) as well as breast cancer (Belivacqua et al., 1989; Barnes et al., 1991; Hennesy et al., 1991; Hirayama et al., 1991; Royds et al., 1993) and hepatocellular carcinoma (Nakayama et al., 1992) . Similarly. the frequent occurrence of Nm23 genetic alterations (loss of heterozygosity or deletion in coding sequences) in metastatic colorectal cancers would suggest a possible tumour metastases-suppressor role for Nm23 in colorectal cancer as well. However, the uniform overexpression of Nm23-H 1 RNA observed in both metastatic and non-metastatic colorectal cancer as well as in metastatic sites themselves is inconsistent with Nm23-H1 being a colorectal cancer metastases suppressor. One proposed hypothesis is that a gene linked to Nm23-Hl and therefore deleted along with the Nm23-Hl allele may actually be a colorectal cancer metastases suppressor (Myeroff & Markowitz, 1993 (Golden et al., 1992) correlates with proliferation of lymphoid cells (Keim et al., 1992) . The observation that a differentiationinhibiting factor in mouse myeloid leukaemic cell lines is the murine homologue of Nm23-H2 (Okabe-Kado et al., 1992) suggests that Nm23 may also be involved in cellular differentiation. Most recently, it has been demonstrated that the Nm23 protein may be a transcriptional factor for c-myc expression (Postel et al., 1993) . Although no relationship has been established between c-myc expression and metastases, increased c-myc expression is frequently noted in colorectal cancer (Erisman et al., 1985; Guillem et al., 1990) and in some systems is associated with decreased cellular differentiation (Spencer & Groudine, 1991 
